The Investigational New Drug Program of the Canadian Cancer Trials Group

Kingston, Ontario
Joined October 2022
Congratulations @Philippe_Bedard on the ESMO-TAT Honorary Award 2025 @CDNCancerTrials
1
3
112
MDICT 2024 recommendations for neoadjuvant early clinical trials now published. Led by ESMO-TAT chairs @lillian_siu @ElenaGarralda @AnastasiosStat2 and MDICT’24 team supported by @myESMO sciencedirect.com/science/ar…
6
2
8
3,297
Congratulations Lillian
1
1
4
325
Congratulations Philippe! Thank you for all your past and current contributions to the IND Program.
1
1
7
819
Dr Helen Mackay presenting our ongoing trial IND.240 #ASCO23 @JEDancey @CDNCancerTrials @CancerResearch @DrPOGaudreau for patients with high grade serous ovarian cancer
1
2
189
(2/3) I also invite you to visit our CCTG IND trial posters at ASCO, including IND.240 (Dr. Helen MacKay): Time: Jun/5/2023, 1:15 PM CDT Hall A meetings.asco.org/abstracts-… @INDProgramCCTG @CDNCancerTrials #immunotherapy #ovariancancer
1
293
Dr Quincy Chu concluding his presentation of IND.227, a collaboration of @istitutotumori @IFCTlung @CDNCancerTrials
3
9
312
Great to have worked again with our long-standing collaborators in Naples - un grande piacere aver collaborato nuovamente con NCI Napoli
1
2
52